When considering therapeutic drug monitoring, what is the definition of bioavailability?
A) The proportion of a drug that reaches the systemic circulation unchanged after administration
B) The proportion of a drug that is metabolized by the liver before reaching the systemic circulation
C) The proportion of a drug that is excreted unchanged in the urine after administration
D) The proportion of a drug that is bound to plasma proteins and unavailable for therapeutic action